Northwestern Medicine scientists have discovered that a specific type of white blood cell’s behavior may explain how rheumatoid arthritis develops.
Northwestern Medicine scientists identified the same protein deposits that are usually found in the brains of ALS patients in the retina, opening a new potential avenue for diagnosing and tracking the disease.
Northwestern Medicine scientists created a more objective, precise and quicker way to test the effectiveness of multiple sclerosis drugs that may promote the repair of myelin, a protective sheath on neurons.
Northwestern Medicine scientists discovered that genetic mutations in the KCNB1 potassium channel gene can result in severe early onset epilepsy.
Inhibiting a ubiquitin ligase stops tumor growth during hypoxia, a common characteristic of lung and brain cancers.
Nehal Gosalia, ’14 PhD, examined the role of architectural proteins in regulation of expression of the cystic fibrosis gene.
Northwestern Medicine scientists found that lesions seen in MRIs of knees without any x-ray signs of osteoarthritis predict the development of persistent symptoms of the disease and the first appearance of cartilage damage.
Northwestern Medicine scientists discovered a method to promote organ transplant tolerance by limiting the immune response in a novel way.
Northwestern Medicine scientists have developed the first animal model for ALS dementia, a form of ALS that also damages the brain, allowing for direct monitoring of test drugs to determine if they work.
Northwestern Medicine scientists developed the first blood test to diagnose major depression in adults and to predict who will benefit from cognitive behavioral therapy.
Notifications